Record Date Set for Extraordinary General Meeting to Determine Shareholder Rights, No Direct Impact on Shareholder Value


  • OliX has set July 7, 2026 as the record date to determine shareholders eligible to attend the extraordinary general meeting, a routine procedure under Article 12 of its articles of incorporation.
  • No book closure period is established; under the Electronic Registration Act, rights are confirmed solely by the record date without physical share movement.
  • This record date setting does not involve share cancellation, capital increase, or dividends, and thus has no direct financial impact on shareholder value.
  • [AI Summary]The record date setting is a standard administrative step to identify voting shareholders, carrying no capital or cash flow changes, resulting in a neutral impact on shareholder value. Investors should focus on the agenda of the upcoming EGM.

KOSDAQ Filing Information


  • Filing: Setting of Record Date or Shareholder Registry Closure Period
  • Company: OliX Pharmaceuticals (226950)
  • Submission: OliX Pharmaceuticals, Inc.
  • Receipt: 06-01-2026
  • Under KRX KOSDAQ Market Division